Sutaria Saumya 4

What Happened Saumya Sutaria, CEO and Director of Tenet Healthcare (THC), received a grant of 245,592 shares as a performance-based restricted stock award. The Form 4 lists the transaction as an acquisition (code A) of 245,592 shares at an acquisition price of $0.00 (total $0) dated February 13, 2026.

Key Details

• Transaction date: 2026-02-13; Form 4 filed: 2026-02-17 (filed within the Form 4 two-business-day window given the Feb 16 federal holiday).
• Transaction type/code: Award/Grant (A) — performance-based restricted stock.
• Shares acquired: 245,592; reported acquisition price: $0.00 (total $0 on Form 4).
• Shares owned after transaction: Not stated in the summary provided (see filing for holdings totals).
• Footnote: The award was earned when the Human Resources Committee certified achievement of performance targets for the period Jan 1, 2023–Dec 31, 2025.
• No 10b5-1 plan, tax-withholding sale, or exercise/sale noted in the provided transaction details.

Context This was an earned performance award (compensation), not an open-market purchase or sale. Such grants reflect achievement of company-set performance goals and are different from an insider buying or selling stock; they do not, by themselves, indicate the insider’s personal trading sentiment. For full holdings, vesting conditions, and any related tax-withholding transactions, consult the complete Form 4 filing (Accession No. 0001193125-26-055526).